Quantum Computing (QUBT): Evaluating High Valuation After Surging 1,237% in the Past Year

Quantum Computing (QUBT) has recently caught some attention in the market. While there is no single news event driving the current movement, its stock performance over the past month raises interesting valuation questions for investors considering the emerging sector.

See our latest analysis for Quantum Computing.

After a meteoric run over the past year, with a total shareholder return of 1,237% and a current share price of $14.97, Quantum Computing is now experiencing some volatility as recent weeks have seen momentum fade. Even with the recent dip, the longer-term performance stands out and keeps investors curious about whether sentiment will turn positive again as the valuation picture evolves.

If Quantum Computing’s latest moves have you thinking bigger, this is a perfect moment to broaden your scope and discover See the full list for free.

With shares now off recent highs but still far above last year’s levels, the key question becomes: Is Quantum Computing undervalued at these prices, or is the future already fully reflected in today’s valuation?

Advertisement

Price-to-Book Ratio of 8.5x: Is it justified?

At a last close price of $14.97, Quantum Computing trades at a price-to-book ratio of 8.5x, which is notably higher than both its industry and peer averages.

The price-to-book ratio compares a company’s market value to its net assets. For an early-stage technology company like Quantum Computing, investors generally use this multiple to gauge how much the market is willing to pay above the company’s book value in anticipation of future growth or innovation.

A ratio of 8.5x is almost four times higher than the US Tech industry average of 2.1x, and significantly above the peer average of 5.6x. This premium suggests the market is pricing in substantial expected growth or breakthroughs, but it is not supported by current profitability or revenue levels.

With these elevated valuation expectations, there is little room for disappointment. If the company fails to deliver on growth, the multiple could quickly compress to align with industry norms.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-Book Ratio of 8.5x (OVERVALUED)

However, looming risks, such as the company’s significant net losses and steep recent share price declines, could quickly challenge the current premium valuation.

Find out about the key risks to this Quantum Computing narrative.

Build Your Own Quantum Computing Narrative

If you see things differently or want to investigate the numbers for yourself, you can craft your own view in just a few minutes, so Do it your way.

A great starting point for your Quantum Computing research is our analysis highlighting 1 key reward and 5 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Smart moves now can open doors to better returns and fresh opportunities. Don’t let these promising stocks slip off your radar. Curate your watchlist with these game-changers today.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Quantum Computing might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqCM:QUBT

Quantum Computing

An integrated photonics company, provides quantum machines to commercial and government markets in the United States.

Flawless balance sheet with high growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
48 users have followed this narrative
2 users have commented on this narrative
8 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7720.1% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
83 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
190 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0